QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gradolatto, A. Articles by Teyssier, C. Search for Related Content PubMed PubMed Citation Articles by Gradolatto, A. Articles by Teyssier, C.

METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER

Unité Mixte de Recherche de Toxicologie Alimentaire, Institut National de la Recherche Agronomique, Dijon cedex, France

The metabolism of apigenin, a low estrogenic flavonoid phytochemical, was investigated in rat using liver models both in vitro (subcellular fractions) and ex vivo (isolated perfused liver). In vitro, phase I metabolism led to the formation of three monohydroxylated derivatives: luteolin which was the major metabolite (K_m = 22.5 ± 1.5 µM; V_max = 5.605 ± 0.090 nmol/min/mg protein, means ± S.E.M.), scutellarein, and iso-scutellarein. These oxidative pathways were mediated by cytochrome P450 monooxygenases (P450s). The use of P450 inhibitors and inducers showed that CYP1A1, CYP2B, and CYP2E1 are involved. In vitro studies of phase II metabolism indicated that apigenin underwent conjugation giving three monoglucuronoconjugates and one monosulfoconjugate. Luteolin led to the formation of four monoglucuronoconjugates, two sulfoconjugates, and one methylconjugate identified as diosmetin. Ex vivo during the apigenin perfusion of an isolated rat liver, none of the phase I metabolites could be recovered. In contrast, two monoglucuronoconjugates and one of the sulfoconjugates of apigenin already identified in vitro were recovered. Moreover, two new derivatives were isolated and identified as a diglucuronoconjugate and a glucuronosulfoconjugate. This work provides new data about the metabolism of apigenin and shows the interest value of using various experimental models in metabolic studies.

This article has been cited by other articles:

				S. B. Lotito and B. Frei Dietary Flavonoids Attenuate Tumor Necrosis Factor {alpha}-induced Adhesion Molecule Expression in Human Aortic Endothelial Cells: STRUCTURE-FUNCTION RELATIONSHIPS AND ACTIVITY AFTER FIRST PASS METABOLISM J. Biol. Chem., December 1, 2006; 281(48): 37102 - 37110. [Abstract] [Full Text] [PDF]

				X. Chen, L. Cui, X. Duan, B. Ma, and D. Zhong PHARMACOKINETICS AND METABOLISM OF THE FLAVONOID SCUTELLARIN IN HUMANS AFTER A SINGLE ORAL ADMINISTRATION Drug Metab. Dispos., August 1, 2006; 34(8): 1345 - 1352. [Abstract] [Full Text] [PDF]

				A. Gradolatto, J.-P. Basly, R. Berges, C. Teyssier, M.-C. Chagnon, M.-H. Siess, and M.-C. Canivenc-Lavier PHARMACOKINETICS AND METABOLISM OF APIGENIN IN FEMALE AND MALE RATS AFTER A SINGLE ORAL ADMINISTRATION Drug Metab. Dispos., January 1, 2005; 33(1): 49 - 54. [Abstract] [Full Text] [PDF]